Literature DB >> 17642837

Evaluation of dexamethasone pulse therapy in systemic sclerosis.

Q M Ahmad1, I Hassan, I Majid.   

Abstract

The treatment of systemic sclerosis, a multisystem disorder, is for from satisfactory. Dexamethasone pulse therapy was started in 25 patients of systemic sclerosis and of the 10 patients who successfully completed the treatment, the results have been quite encouraging. Adverse effects to the pulse were minimal.

Entities:  

Year:  2003        PMID： 17642837

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


  3 in total

1.  Increased incidence of tuberculosis in patients of systemic sclerosis on dexamethasone pulse therapy: a short communication from Kashmir.

Authors:  Qazi Masood Ahmad; Iffat Hassan Shah; Qazi Nauman; Farah Sameem; Javaid Sultan
Journal:  Indian J Dermatol       Date:  2008-01       Impact factor: 1.494

2.  Dexamethasone-cyclophosphamide pulse therapy in progressive systemic sclerosis.

Authors:  Vishalakshi Viswanath; Amey D Sonavane; Aditi C Doshi; Mrunal G Parab
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

3.  Dexamethasone pulse therapy in patients of systemic sclerosis: is it a viable proposition? A study from kashmir.

Authors:  Farah Sameem; Iffat Hassan; Qazi Masood Ahmad; Dilshad Khan; Imran Majeed; M A Kamili; Parvaiz A Shah
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.